ArticleTranslational psychiatry2025
The involvement of 5-HT was necessary for EA-mediated improvement of post-stroke depression.
Article in Translational psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Efficacy and safety of electroacupuncture for post-stroke depression: a systematic review and meta-analysis.Frontiers in neurology · 2025Pooled it
- Acupuncture with the Sancai Acupoint Matching Method for Primary Insomnia: A Randomized Controlled Trial.Nature and science of sleep · 2026Trial
- Mechanism-Driven Translation of Electroacupuncture for Depression: Bridging the Gap Between Preclinical and Clinical Research.Neuropsychiatric disease and treatment · 2026Review
- Effects of a 12-week high-intensity interval training intervention on serum neurotransmitters and autonomic function in mild-to-moderate depression.Frontiers in psychology · 2026Article
- Central Neurobiological Mechanisms of Acupuncture in Post-Stroke Depression: Multi-Target and Network-Based Regulation.Neuropsychiatric disease and treatment · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
The prevalence of depression is as high as about 30% within five years after stroke, while there is still no breakthrough in the Western medical treatments for post-stroke depression (PSD) in clinical practice. The traditional acupuncture treatment has been practiced to be effective for the therapy of PSD, but its mechanism still needs to be elucidated. With a combination of methods, including behavioral testing, immunofluorescence, in vivo electrophysiological recording, mRNA sequencing, genetic modulation, and in vivo fiber recording techniques, this study showed that electroacupuncture (EA) at Baihui (GV20) and Shenting (GV24) acupoints improved the depressive-like behaviors and neuronal electrophysiological activities in PSD model mice, which was established by bilateral injection of collagenase IV into the medial prefrontal cortex (mPFC). Moreover, it was found that the EA-mediated improvement was comparable to that of fluoxetine. The mRNA sequence analysis indicated that the 5-hydroxytryptamine (5-HT) system was involved in the pathogenesis of PSD. Meanwhile, the number of 5-HT positive neurons in the dorsal raphe nucleus (DRN) and 5-HT in the mPFC was significantly decreased, and ablation of neurons in the DRN could prevent the efficacy of EA. The neuronal activity of excitatory and inhibitory neurons in mPFC can be modulated by chemogenetic activation or inhibition of the TPH2-positive neurons in the DRN projecting to the mPFC. Together, our results have provided the insight of the biological mechanism underlying acupuncture in the treatment of PSD and revealed the scientific connotation of acupuncture in both clinical and scientific value.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.